Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. (Q38292885)

PubMed publication ID

1 September 2017

3 references

28 October 2020

19 July 2021

Curcumin and inflammatory bowel disease: potential and limits of innovative treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

inflammatory bowel diseases

13 May 2020

main subject

2 references

28 October 2020

19 July 2021

0 references

0 references

non-steroidal anti-inflammatory drug

1 reference

28 October 2020

anti-inflammatory agent

1 reference

19 July 2021

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

Annalisa Marcuzzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

Anna Monica Rosaria Bianco

13 May 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

author name string

Paola Maura Tricarico

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

Valentina Zanin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

Martina Girardelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

16 December 2014

3 references

PubMed publication ID

1 September 2017

28 October 2020

19 July 2021

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

28 October 2020

19 July 2021

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

page(s)

21127-21153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

Creative Commons Attribution

13 May 2020

copyright license

2 references

28 October 2020

19 July 2021

0 references

Curcumin, a component of turmeric: from farm to pharmacy

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Conundrum and Therapeutic Potential of Curcumin in Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Pharmacology of Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Bioactive food components, inflammatory targets, and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Naturally occurring phytochemicals for the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Geographical variability and environmental risk factors in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Early life factors and risk of inflammatory bowel disease in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Antibiotic exposure and IBD development among children: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Association Between the Use of Antibiotics in the First Year of Life and Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Association Between the Use of Antibiotics and New Diagnoses of Crohn's Disease and Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

The inflammatory bowel diseases and ambient air pollution: a novel association

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Role of diet in the development of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

IBD and IBD mimicking enterocolitis in children younger than 2 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Mevalonate kinase deficiency and IBD: shared genetic background.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

The diagnostic approach to monogenic very early onset inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Cytokine-based therapies for Crohn's disease--new paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Immunopathology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Biologic therapy for inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Adverse effects of biologics used for treating IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Update in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin as "Curecumin": from kitchen to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin--from molecule to biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin induces paraoxonase 1 in cultured hepatocytes in vitro but not in mouse liver in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Antioxidant therapeutic advances in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Epigenetic changes induced by curcumin and other natural compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin-induced histone hypoacetylation: the role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Anti cancer effects of curcumin: cycle of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin decreases specificity protein expression in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Action of curcumin on the cytochrome P450-system catalyzing the activation of aflatoxin B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Effect of Curcumin on the Aryl Hydrocarbon Receptor and Cytochrome P450 1A1 in MCF-7 Human Breast Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Mechanism(s) of turmeric-mediated protective effects against benzo(a)pyrene-derived DNA adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-D: -aspartate-induced intracellular Ca(2+) increase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcuminoids modulates oxidative damage and mitochondrial dysfunction in diabetic rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin attenuates aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Therapeutic roles of curcumin: lessons learned from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

21 January 2018

The targets of curcumin.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Improving the solubility and pharmacological efficacy of curcumin by heat treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Therapeutic potential of curcumin in gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin has bright prospects for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin therapy in inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin attenuates DNB-induced murine colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

NF-κB pathways in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

The resolution of inflammation: anti-inflammatory roles for NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Possible new role for NF-kappaB in the resolution of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Antidiabetic potential of the heme oxygenase-1 inducer curcumin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-α-induced NF-κB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Free radical mediated release of histamine from rat mast cells induced by drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Effects of benzylidenecyclopentanone analogues of curcumin on histamine release from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Nanotechnology-applied curcumin for different diseases therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Detection of Crohn disease lesions of the small and large bowel in pediatric patients: diagnostic value of MR enterography versus reference examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Phenotype and disease course of early-onset pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191221127

Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu

21 January 2018

1 reference

12 December 2020

Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex

1 reference

12 December 2020

Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein

1 reference

12 December 2020

Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels

1 reference

12 December 2020

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.

1 reference

12 December 2020

Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines

1 reference

12 December 2020

Anticancer potential of curcumin: preclinical and clinical studies.

1 reference

12 December 2020

Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis

1 reference

12 December 2020

Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons.

1 reference

12 December 2020

Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1

1 reference

12 December 2020

Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation

1 reference

12 December 2020

Curcumin is an inhibitor of p300 histone acetylatransferase

1 reference

12 December 2020

Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis

1 reference

12 December 2020

Distinct mechanisms underlie distinct polyphenol-induced neuroprotection

1 reference

12 December 2020

Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis

1 reference

12 December 2020

Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer

1 reference

12 December 2020

Dietary patterns and risk for Crohn's disease in children

1 reference

12 December 2020

The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats

1 reference

12 December 2020

Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent

1 reference

12 December 2020

Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells

1 reference

12 December 2020

Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells

1 reference

12 December 2020

PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes

1 reference

12 December 2020

Environmental risk factors for inflammatory bowel disease

1 reference

12 December 2020

Curcumin for clinical and endoscopic remission in ulcerative colitis

1 reference

12 December 2020

Curcumin for inflammatory bowel disease: a review of human studies

1 reference

12 December 2020

Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC-7721 cells

1 reference

12 December 2020

A common genetic background could explain early-onset Crohn’s disease

1 reference

12 December 2020

Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line.

1 reference

12 December 2020

Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor

1 reference

12 December 2020

A clinical review of recent findings in the epidemiology of inflammatory bowel disease

1 reference

12 December 2020

Demethoxycurcumin from Curcuma longa rhizome suppresses iNOS induction in an in vitro inflamed human intestinal mucosa model

1 reference

12 December 2020

Synthesis of novel curcumin analogues for inhibition of 11β-hydroxysteroid dehydrogenase type 1 with anti-diabetic properties

1 reference

12 December 2020

DNA methylation changes in inflammatory bowel disease

1 reference

12 December 2020

Curcumin analogue A501 induces G2/M arrest and apoptosis in non-small cell lung cancer cells.

1 reference

12 December 2020

Infliximab in inflammatory bowel disease: attention to adverse events

1 reference

12 December 2020

Curcumin Inhibits STAT3 Signaling in the Colon of Dextran Sulfate Sodium-treated Mice

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

12 December 2020

Spectral and photochemical properties of curcumin

1 reference

12 December 2020

Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin

1 reference

12 December 2020

Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53

1 reference

12 December 2020

10.3390/MOLECULES191221127

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json

13 May 2020

PubMed publication ID

25521115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271352&resulttype=core&format=json